Protocolo de orientação farmacêutica no processo de alta hospitalar de recém-nascidos em tratamento para toxoplasmose

Abstract

The use of clinical protocols in hospitals is widely adopted in countries with well-established healthcare systems, allowing the implementation of personalized pharmaceutical care. In maternal and child health, congenital toxoplasmosis is a serious infection, with a high prevalence in Brazil, and early diagnosis is crucial to prevent complications in newborns. This work aimed to develop a protocol and a pharmaceutical guidance booklet for parents or guardians of newborns with congenital toxoplasmosis, with the aim of guiding the healthcare team and ensuring adequate treatment. The methodology consisted of preparing the protocol and developing the booklet, based on Technical Note No. 100/2022 and validation by the MEAC/UFC team of pharmacists, ensuring compliance with good practices and EBSERH requirements. As a result, the aforementioned documents were created that address the definition of the disease, mode of transmission, clinical manifestations, treatment, surveillance and guidance on the correct use of the medications used. The protocol and booklet aim to improve the care of newborns with congenital toxoplasmosis, benefit patients and their families, in addition to improving MEAC and public health services in the city of Fortaleza, since pharmaceutical guidance contributes to greater adherence to the treatment and prevention of associated complications.